Xometry (XMTR) to Post Earnings on Tuesday

Xometry (NASDAQ:XMTR) is anticipated to announce its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect the company to post earnings of $0.12 per share and revenue of $215.2230 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Tuesday, August 4, 2026 at 8:30 AM ET.

Xometry (NASDAQ:XMTR) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.05. Xometry had a negative net margin of 7.01% and a negative return on equity of 4.37%. The firm had revenue of $205.14 million during the quarter, compared to analyst estimates of $188.46 million. During the same quarter in the prior year, the firm posted ($0.05) earnings per share. Xometry’s quarterly revenue was up 35.9% on a year-over-year basis. On average, analysts expect Xometry to post $-0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Xometry Stock Performance

Shares of Xometry stock opened at $85.92 on Tuesday. The firm has a market cap of $4.45 billion, a PE ratio of -84.24 and a beta of 1.27. Xometry has a 52 week low of $30.63 and a 52 week high of $106.08. The business’s fifty day simple moving average is $91.27 and its 200-day simple moving average is $66.93. The company has a quick ratio of 1.76, a current ratio of 1.78 and a debt-to-equity ratio of 0.86.

Insider Transactions at Xometry

In other news, CFO James Miln sold 2,392 shares of the firm’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $93.29, for a total value of $223,149.68. Following the transaction, the chief financial officer directly owned 179,131 shares in the company, valued at approximately $16,711,130.99. This trade represents a 1.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Lukas Alexander Biewald bought 47,058 shares of the company’s stock in a transaction on Wednesday, June 3rd. The stock was bought at an average cost of $85.00 per share, for a total transaction of $3,999,930.00. Following the completion of the transaction, the director directly owned 55,134 shares of the company’s stock, valued at $4,686,390. This trade represents a 582.69% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders sold 80,496 shares of company stock valued at $7,124,340 over the last 90 days. Corporate insiders own 9.10% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada raised its holdings in shares of Xometry by 5.0% during the first quarter. Royal Bank of Canada now owns 60,669 shares of the company’s stock worth $1,511,000 after acquiring an additional 2,899 shares in the last quarter. AQR Capital Management LLC bought a new position in Xometry in the first quarter worth $692,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Xometry by 7.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,054 shares of the company’s stock valued at $649,000 after acquiring an additional 1,877 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in Xometry by 26.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company’s stock valued at $11,281,000 after buying an additional 95,154 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Xometry by 476.1% in the 2nd quarter. Invesco Ltd. now owns 238,390 shares of the company’s stock worth $8,055,000 after purchasing an additional 197,013 shares during the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on XMTR shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Xometry in a report on Friday, May 29th. Cantor Fitzgerald upgraded Xometry from a “neutral” rating to an “overweight” rating and set a $62.00 price target on the stock in a research report on Thursday, April 30th. Citizens Jmp boosted their price target on shares of Xometry from $75.00 to $100.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. Wedbush started coverage on Xometry in a research report on Thursday, July 16th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, The Goldman Sachs Group reiterated a “neutral” rating and set a $78.00 price target on shares of Xometry in a research report on Friday, May 8th. Six research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Xometry presently has an average rating of “Hold” and an average target price of $84.25.

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.